SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

ZIM Laboratories secures marketing authorization for ‘Dabigatran Etexilate’ in Italy

20 May 2026 Evaluate

ZIM Laboratories has secured Marketing Authorization from Agenzia Italiana del Farmaco (AIFA), the Italian Medicines Agency, for its anticoagulant product ‘Dabigatran Etexilate’ (75 mg, 110 mg & 150 mg hard capsules), in Italy via DCP to its wholly owned European subsidiary, SIA ZIM Laboratories, Latvia. This authorisation will facilitate faster approvals in other European Union countries as well as the UK and other markets globally resulting in better commercialisation opportunities.

Dabigatran Etexilate Capsules are indicated for the prevention and treatment of thromboembolic disorders, including stroke prevention in patients with non-valvular atrial fibrillation. The product has been developed using the company’s proprietary non-tartaric acid-based formulation design incorporating a novel excipient system and has demonstrated bioequivalence with the innovator product.

ZIM Laboratories manufactures, formulates, and distributes drug delivery systems to develop generic pharmaceutical products.

Zim Laboratories Share Price

108.60 5.15 (4.98%)
09-Jun-2026 14:56 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.10
Dr. Reddys Lab 1266.60
Cipla 1380.90
Zydus Lifesciences 1107.00
Lupin 2270.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×